Market Definition 

Dexketoprofen is a nonsteroidal anti-inflammatory drug. Dexketoprofen is used for short-term painful conditions such as muscular sprains and strains, period (menstrual) pain, and toothache. Dexketoprofen blocks the effect of cyclo-oxygenase (COX) enzymes. Cyclo-oxygenase (COX) enzymes help to make prostaglandins. Prostaglandins are produced at place of injury and cause pain and inflammation. Dexketoprofen block the effect of COX enzymes, fewer prostaglandins are produced, which help to reduce the pain. 

Global dexketoprofen market is estimated to reach $XX million by 2026; growing at a CAGR of 3.9% till 2026. 

Market Dynamics 

Rising prevalence of acute pain has driven the market demand. Dexketoprofen is a non-steroidal anti-inflammatory drug used for acute pain. Dexketoprofen is used for the treatment of short-term painful conditions such as muscular sprains and strains, period (menstrual) pain, and toothache. According to the American Dental Association, each year, more than 2.1 million people are visiting the hospital for dental pain in the United States. In Europe, 16% of the population have experienced a toothache and painful gums in 2017. According to the National Health Service, around 80% of women experience period pain at in their lifetime. 5% to 10% of women experience severe pain due to menstrual pain. According to this statistic, around 31.83 million women in the U.S. reported menstrual pain or pre-menstrual syndrome (PMS) in 2019. In the United States, more than 23,000 people per day and 1 million ankle injuries occur each year, of which 85% of them are sprains. Further, clinical investigation and approvals for dexketoprofen is a key driving factor of the market. However, the side effect of dexketoprofen drugs might hamper market growth. Some of the side effects of dexketoprofen include Nausea and vomiting, stomach pain, diarrhea, digestive problems, dizziness, disturbed sleep, nervousness, headache, palpitations, flushing, stomach problems, constipation, dry mouth, flatulence, skin rash, tiredness, pain, feeling feverish and shivering, and malaise are the most common side effects of dexketoprofen. The Severe side effect of dexketoprofen can cause thrombocytopenia and anemia with bleeding episodes. Dexketoprofen is also associated with an increased risk of myocardial infarction. Moreover, increasing consumption of dexketoprofen drugs by workers and athlete due to sprains and strains would provide lucrative opportunities for the market in the coming years. 

Market Segmentation 

The global dexketoprofen market is mainly classified based on type and application. Type is further segmented into Tablet, Injection, and Gel. By application, the market is divided into Muscular Sprains and Strains, Menstrual Pain, and Others.  

Based on type, the tablet was dominating the dexketoprofen market in 2019, owing to the agreement between companies to develop and market dexketoprofen jointly, rising number of clinical investigation on dexketoprofen, and increasing regulatory approval of dexketoprofen tablet. For instance, the orally administered a fixed-dose combination of dexketoprofen 25 mg and tramadol 75 mg was approved in Europe for short-term treatment of moderate-to-severe acute pain. This indication encompasses a wide range of post-operative and non-surgical painful conditions. 

Regional Analysis 

Based on geography, the global dexketoprofen market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

North America was dominating the dexketoprofen market in 2019, owing to the increasing clinical studies of dexketoprofen and launch of dexketoprofen in combination with other drugs for the treatment of acute pain. Moreover, increasing consumption of dexketoprofen drugs by workers due to sprains and strains has driven the market demand. Dexketoprofen is used for the treatment of short-term painful conditions such as muscular sprains and strains. The rising muscular sprains and strains at the workplace in the U.S has raised the demand for dexketoprofen. According to the U.S. Bureau of Labor and Statistics, in 2017, 2.8 million cases of sprains and strains were reported by employees within the private sector. Sprains and strains involving the back, which accounted for 43% of the 1.3 million injuries and illnesses in private industry. Around 1 million ankle injuries occur each year, of which 85% of them are sprains. The use of dexketoprofen gel results in the clinical success of more than 50% pain reduction. 

Competitive landscape 

Key players operating in the dexketoprofen industry include Menarini Group, Emcure Pharmaceuticals Ltd, Mylan, Sandoz, Teva, Sanofi, Merck, Accord Healthcare, Cipla, and Sotex. 

Increasing clinical investigation on dexketoprofen for the treatment of acute pain, the collaboration between companies to develop dexketoprofen, and commercialization of regulatory approved dexketoprofen for various indications are some of the strategies adopted by the major players. For instance, Menarini Singapore Pte. Ltd., has received approval for Skudexa Film-Coated Tablet 75 MG/ 25 MG. Skudexa is used for short term treatment of moderate to severe acute pain in adult patients whose pain require a combination of tramadol and dexketoprofen. Dexketoprofen drug is available for use in countries of Europe, Asia and Latin America. 

Dexketoprofen Market Key Segments: 

By Type 

• Tablet 
• Injection 
• Gel 

By Application 

• Muscular Sprains and Strains 
• Menstrual Pain 
• Others 

Key Global Dexketoprofen Industry Players 

• Menarini Group 
• Emcure Pharmaceuticals Ltd 
• Mylan 
• Sandoz 
• Teva 
• Sanofi 
• Merck 
• Accord Healthcare 
• Cipla 
• Sotex 

 What Report Provides 

• Full in-depth analysis of the parent Industry 
• Important changes in market and its dynamics 
• Segmentation details of the market 
• Former, on-going, and projected market analysis in terms of volume and value 
• Assessment of niche industry developments 
• Market share analysis 
• Key strategies of major players 
• Emerging segments and regional growth potential